NRC — Human Health Therapeutics Research Centre
At a glance
- No Condition
- Open Date : November 14, 2019
- Professional, scientific and technical services
- Health care and social assistance
- National Research Council Canada
- Government of Canada
Overview
Eligibility criteria
Eligible expenses
There are eligible expenses for this grant focusing on designing, developing, and producing innovative biologics in Canada. Eligible expenses include:
- Costs related to research and development of novel biologics
- Biomanufacturing expenses to improve production processes for complex biologics
- Funding for cell and gene therapies development
Evaluation & selection criteria
There are evaluation and selection criteria for this grant. The evaluation and selection criteria are as follows:
- Relevance of the project to advancing novel biologics
- Scientific merit and innovation of the proposed research
- Feasibility and technical soundness of the project
- Alignment with the organization's strategic priorities
- Potential impact on public health and patient outcomes
Grant Summary
This grant focuses on designing, developing, and producing innovative biologics in Canada to address complex health challenges such as emerging infections, cancer, and neurological diseases. The National Research Council of Canada collaborates with various entities to advance novel biologics through multidisciplinary expertise and cutting-edge facilities.
Exploring Innovative Biologics Development in Canada
The National Research Council of Canada is at the forefront of biologics development, specializing in the creation of vaccines and therapeutics derived from living organisms. With a focus on addressing pressing health issues like cancer and infections, the NRC leverages its research programs and unique facilities to design, develop, and test novel biologics.
Biologics, such as cell and gene therapies, are key components in treating and preventing diseases, and the NRC's expertise spans the entire biologics development process. From designing high-potential candidates to optimizing bioprocesses in compliance with good manufacturing practices, the NRC collaborates with industry, academia, and government to drive innovation in biologics production.
The NRC's multidisciplinary approach involves small-scale manufacturing capabilities for evaluating biologic candidates, in vivo and in vitro testing expertise for preclinical R&D, and advanced bioprocess R&D capabilities for process improvement. With a focus on personalized and off-the-shelf biologics, the NRC engages in cutting-edge research to enhance the production process for complex biologics.
Through collaboration with industry partners, health networks, and academic institutions, the NRC aims to accelerate the development and production of Canadian-made biopharmaceuticals. By bridging the gap between research and commercialization, the NRC's efforts contribute to the advancement of clinical trial material for innovative biologics in Canada.
